QPS Holding, LLC

QPS Holding, LLC

QPS is a global, GLP/GCP-compliant contract research organization (CRO) offering full-service pharmaceutical contract R&D services in the US, Europe and Asia with special expertise in Pharmacology, DMPK, Toxicology, Bioanalysis, Translational Medicine, Clinical Trials and Clinical Research Services.

Visit Website


  • APAC
  • Australia
  • Europe
  • North America
  • South America

Therapeutic Areas

  • Bone / Osteoporosis
  • Cardiovascular
  • Cell
  • CNS
  • Dermatology
  • Diabetes
  • Endocrinology
  • Gastroenterology
  • Gene
  • Hematology
  • Hepatology
  • Immunology
  • Infectious Diseases
  • Inflammation
  • Metabolic Diseases
  • Neurology
  • Oncology
  • Ophthalmology
  • Orthopedics
  • Pharmacology / Toxicology
  • Psychiatry
  • Pulmonary
  • Respiratory
  • Rheumatology
  • Urology
  • Vaccines

QPS is an award-winning global CRO providing discovery, bioanalysis, preclinical and clinical drug development services since 1995. Our mission is to accelerate pharmaceutical breakthroughs across the globe by delivering custom-built research services in Toxicology, Pharmacology, DMPK, Preclinical and Clinical Drug Development.

At QPS we believe in developing close and long-lasting relationships with our clients on the basis of trust and mutual respect. This mutual trust, combined with the agile approach we offer as a specialty CRO, helps improve the quality of your outsourced drug development work and reduces the degree of required oversight.

Pharmacology: QPS offers an array of predictive disease models, as well as unparalleled experience with validated in vitro and in vivo models covering the majority of pharmacological targets for NASH, IBD and wound healing.

Toxicology: Over the past two decades, QPS has performed thousands of GLP studies for pharmaceutical and biotechnology companies, covering many different disease areas. This vast experience attests to our ability to effectively deliver high-quality toxicology data solutions at our preclinical site in Asia.

DMPK: With immediate access to a team of senior scientists with decades of pharmaceutical and biotech experience, QPS guides you through the appropriate preclinical studies across a broad range of compound structures and therapeutic targets.

Bioanalysis: QPS is built on a worldwide network of resources in bioanalysis for small molecules and biologics, with state-of-the-art facilities in the U.S., Europe and Asia. Find out how a strategic outsourcing alliance with QPS can provide you with world-class operational and service excellence.

Translational Medicine: QPS offers specialized biomarker assay capabilities that support the development of targeted therapies and personalized medicines.

Clinical Development: At QPS, we have built a world-class clinical operations services model.

We offer industry-leading full-service Phase I – IV clinical trial capabilities, including medical and regulatory affairs, project & data management, multiple Phase I clinics, clinical pharmacology, trial monitoring, and more.


Partners are trained on the functionality of the electronic data capture (EDC) and clinical data management (CDM) system, process optimization exercises and scope of Medidata Rave services. This Accreditation teaches the staff to perform end user training, user and site administration, study build, reporting, outputs and amendment manager.
Partners are trained on the functionality of the RTSM Application, process optimization, best practices using RTSM, and scope of RTSM services. This Accreditation teaches Partners to conduct randomization and clinical trial supply management services (RTSM). RTSM Accreditation is dependent on the successful completion of the Rave EDC Accreditation.